These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 784944

  • 21. Betaxolol and levobunolol: new beta-blocking antiglaucoma agents.
    Tierney DW.
    J Am Optom Assoc; 1987 Sep; 58(9):722-7. PubMed ID: 2895783
    [Abstract] [Full Text] [Related]

  • 22. Comparison of ophthalmic beta-blocking agents.
    Lesar TS.
    Clin Pharm; 1987 Jun; 6(6):451-63. PubMed ID: 2891463
    [Abstract] [Full Text] [Related]

  • 23. Relative beta adrenergic receptor blocking activity in dogs after intravenous and intraportal vein administration: bunolol, propranolol, their levo isomers and sotalol.
    Kaplan HR, Commarato MA.
    J Pharmacol Exp Ther; 1973 May; 185(2):395-405. PubMed ID: 4145046
    [No Abstract] [Full Text] [Related]

  • 24. An approach to peripheral vasodilator-beta-adrenergic blocking agents.
    Baldwin JJ, Hirschmann R, Lumma PK, Lumma WC, Ponticello GS, Sweet CS, Scriabine A.
    J Med Chem; 1977 Aug; 20(8):1024-9. PubMed ID: 19628
    [Abstract] [Full Text] [Related]

  • 25. Cardiovascular effects of levobunolol eyedrops in healthy subjects.
    Weiser BA, Feldman F, Ananthanarayan CR, Gilbert BW, Haq A.
    Can J Ophthalmol; 1991 Jun; 26(4):211-4. PubMed ID: 1889023
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Treatment of elevated intraocular pressure with concurrent levobunolol and pilocarpine.
    David R, Ober M, Masi R, Elman J, Novack GD, Sears ML, Batoosingh AL.
    Can J Ophthalmol; 1987 Jun; 22(4):208-11. PubMed ID: 2886200
    [Abstract] [Full Text] [Related]

  • 28. Effects of topical 0.5% levobunolol alone or in association with 2% dorzolamide compared with a fixed combination of 0.5% timolol and 2% dorzolamide on intraocular pressure and heart rate in dogs without glaucoma.
    Scardillo A, Pugliese M, De Majo M, Niutta PP, Pugliese A.
    Vet Ther; 2010 Jun; 11(3):E1-6. PubMed ID: 20960417
    [Abstract] [Full Text] [Related]

  • 29. Stereoselectivity in the metabolism of the beta-adrenergic blocking agent, (+/-)-1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol hydrochloride (xibenolol hydrochloride, D-32), in man.
    Honma S, Ito T, Kambegawa A.
    Chem Pharm Bull (Tokyo); 1985 Feb; 33(2):760-8. PubMed ID: 2861914
    [No Abstract] [Full Text] [Related]

  • 30. Binding affinities of ocular hypotensive beta-blockers levobetaxolol, levobunolol, and timolol at endogenous guinea pig beta-adrenoceptors.
    Sharif NA, Xu SX.
    J Ocul Pharmacol Ther; 2004 Apr; 20(2):93-9. PubMed ID: 15117564
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Enantiomers of 8-(3-tert-butylamino-2-hydroxypropoxy)-3,4-dihydro-3-oxo-2H- (1,4)benzothiazine: racemic resolution, chiral synthesis and biological activity.
    Schiaffella F, Fringuelli R, Cecchetti V, Fravolini A, Angeli P, Marucci G.
    Farmaco; 1990 Dec; 45(12):1299-307. PubMed ID: 1982489
    [Abstract] [Full Text] [Related]

  • 35. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
    Hara Y, Sato E, Miyagishi A, Aono S, Nakatani H.
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
    [Abstract] [Full Text] [Related]

  • 36. Elevation of ventricular fibrillatory threshold by beta-adrenergic blocking agents.
    Baum T, Peters JR, Eckfeld DK, Varner LL, Dinish J, Metz N, Shropshire AT.
    Arch Int Pharmacodyn Ther; 1972 Dec; 200(2):292-300. PubMed ID: 4405153
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Antagonism of cardiac arrhythmias by beta-adrenoreceptor blocking agents.
    Laddu AR, Kumakura S, Somani P.
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):168-81. PubMed ID: 4404932
    [No Abstract] [Full Text] [Related]

  • 40. The effect of topical beta-adrenoceptor blocking agents on pulsatile ocular blood flow.
    Morsman CD, Bosem ME, Lusky M, Weinreb RN.
    Eye (Lond); 1995 Nov; 9 ( Pt 3)():344-7. PubMed ID: 7556745
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.